Jacksonville South Dialysis Center in Jacksonville, Florida - Dialysis Center

Jacksonville South Dialysis Center is a medicare approved dialysis facility center in Jacksonville, Florida and it has 16 dialysis stations. It is located in Duval county at 14965 Old St Augustine Rd Unit 114, Jacksonville, FL, 32258. You can reach out to the office of Jacksonville South Dialysis Center at (904) 880-9494. This dialysis clinic is managed and/or owned by Davita. Jacksonville South Dialysis Center has the following ownership type - Profit. It was first certified by medicare in February, 2009. The medicare id for this facility is 102873 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameJacksonville South Dialysis Center
Location14965 Old St Augustine Rd Unit 114, Jacksonville, Florida
No. of Dialysis Stations 16
Medicare ID102873
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


14965 Old St Augustine Rd Unit 114, Jacksonville, Florida, 32258
(904) 880-9494

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Jacksonville South Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1255587531
Organization NameJacksonville South Dialysis Center
Doing Business AsTotal Renal Care Inc
Address14965 Old Saint Augustine Rd Jacksonville, Florida, 32258
Phone Number(904) 880-9494

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.66%67%
Patients who reported that nephrologists usually communicated and cared for them.18%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.16%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).70%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).18%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).12%14%

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.71%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.18%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.11%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).69%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).28%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).3%12%

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 80%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.20%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).70%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).23%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).7%12%

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data67
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL22

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center111
    Adult patient months included in Kt/V greater than or equal to 1.2861
    Percentage of adult patients getting regular hemodialysis at the center93
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

    Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

    Somaxon second-quarter net loss reduces to $5.7 million

    Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

    AACN to grant nearly $200,000 to support acuity and critical care nursing practice

    The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

    MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

    MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

    Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

    Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

    Read more Medical News

    › Verified 3 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center15
    Adult patient months included in Kt/V greater than or equal to 1.7103
    Percentage of adult patients getting regular peritoneal dialysis at the center93
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

    Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

    Somaxon second-quarter net loss reduces to $5.7 million

    Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

    AACN to grant nearly $200,000 to support acuity and critical care nursing practice

    The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

    MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

    MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

    Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

    Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

    Read more Medical News

    › Verified 3 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Jacksonville South Dialysis Center with elevated calcium levels.

Patients with hypercalcemia127
Hypercalcemia patient months992
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor130
Patients with Serumphosphor less than 3.5 mg/dL8
Patients with Serumphosphor from 3.5 to 4.5 mg/dL28
Patients with Serumphosphor from 4.6 to 5.5 mg/dL31
Patients with Serumphosphor from 5.6 to 7 mg/dL18
Patients with Serumphosphor greater than 7 mg/dL15

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 135
Patient months included in arterial venous fistula and catheter summaries 801
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment59
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer18

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary103
Hospitalization Rate in facility209.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit340.9
Hospitalization Rate: Lower Confidence Limit139.1

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Jacksonville South Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility25.3 (As Expected)
Readmission Rate: Upper Confidence Limit33.1
Readmission Rate: Lower Confidence Limit18.5

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Jacksonville South Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.32 (As Expected)
SIR: Upper Confidence Limit2.51
SIR: Lower Confidence Limit.62

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Jacksonville South Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 85
Transfusion Rate in facility36.7 (As Expected)
Transfusion Rate: Upper Confidence Limit82.4
Transfusion Rate: Lower Confidence Limit18

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Jacksonville South Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary487
Mortality Rate in facility17.6 (As Expected)
Mortality Rate: Upper Confidence Limit22.6
Mortality Rate: Lower Confidence Limit13.5

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago


Dialysis Facility in Jacksonville, FL

Shands Jacksonville - Esrd
Location: 655 W 8th St, Jacksonville, Florida, 32209
Phone: (904) 244-5448
Baptist Medical Center - Pediatric Dialysis
Location: 800 Prudential Dr, Jacksonville, Florida, 32207
Phone: (904) 202-0436
Dialysis Clinic Inc
Location: 757 Union Street W, Jacksonville, Florida, 32202
Phone: (904) 354-0409
FMC Dialysis Services - North Jacksonville
Location: 10614 Lem Turner Rd, Jacksonville, Florida, 32218
Phone: (904) 768-8576
BMA - Jacksonville
Location: 1944 Atlantic Blvd, Jacksonville, Florida, 32207
Phone: (904) 396-7203

News Archive

Yale New Haven Children's Hospital becomes first in Connecticut to perform pediatric heart transplants

Yale New Haven Children's Hospital (YNHCH) today announced that it has become the first hospital in Connecticut and Rhode Island to receive certification from the United Network of Organ Sharing (UNOS) to perform pediatric heart transplants.

Somaxon second-quarter net loss reduces to $5.7 million

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced financial results for the second quarter ended June 30, 2010.

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

MILabs presents Advanced Imaging Scientist award to Prof. David Townsend

MILabs BV is proud to announce that the Advanced Imaging Scientist award 2014 will be presented to Prof. Dr. David William Townsend for his groundbreaking scientific contribution to diagnose cancer at the Utrecht Life Science seminar on May 19th 2014.

Individual hydroxymethylcytosine molecules in DNA detected by new method involving chemical modification and nanopore analysis

Changes in the bases that make up DNA act as markers, telling a cell which genes it should read and which it shouldn't. In the journal Angewandte Chemie, a British team has now introduced a new method that makes it possible to enrich the rare gene segments that contain the modified base hydroxymethylcytosine and to identify individual hydroxymethylcytosine molecules in DNA. Such modifications are associated with autoimmune diseases and cancer.

Read more Medical News

› Verified 3 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.